Get 20% Free Customization In This Report

Buy this report from - $3456

Hyperphosphatemia Drugs Market by Product (Calcium-based Phosphate Binders, Aluminum-based Phosphate Binders, Magnesium-based Phosphate Binders, and Iron-based Phosphate Binders) and Dosage Form (Tablets, Syrups, and Capsules) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Pharmaceuticals	LI_184408	Pages: NA	Jun 2018 \| 1199 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Hyperphosphatemia is a condition which results in an elevated level of phosphate in the blood. This may occur due to excessive phosphate intake, phosphate shift from intracellular to extracellular space, and decreased phosphate excretion. High phosphate levels in blood can be avoided by use of phosphate binders and dietary constraint of phosphates.

Major factors that drive the market growth are growth in prevalence of chronic diseases and growth in geriatric population. However, stringent regulations by the drug-governing bodies such as FDA and rise in side effects of hyperphosphatemia drugs may impede the market growth. Moreover, high potential in untapped economies, such as India, China, South Africa, and Brazil, is expected to create lucrative opportunities for key players.

The global hyperphosphatemia drugs market is segmented based on product, dosage form, and region. Based on product, it is divided into calcium-based, aluminum-based, magnesium-based, and iron-based phosphate binders. Based on dosage form, it is classified into tablets, syrups, and capsules. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major players, such as Amag Pharmaceuticals, Johnson and Johnson, Keryx Biopharmaceuticals, DSM Biotech Pharmacal, Sun Pharm Inc., Zeria Pharmaceutical, Bruno Pharmaceutical Spa, Fermenta Biotech Ltd, Pfizer Inc. and Roche Diagnostics Corporation are also provided in this report.

Key Benefits

This report provides an extensive analysis of the current and emerging trends and dynamics in the global hyperphosphatemia drugs market.
In-depth analysis is done by constructing market estimations for the key market segments between 2016 and 2023 to identify the prevailing market opportunities.
This study evaluates the competitive landscape and value chain to understand the competitive environment across the geographies.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Extensive analysis of all regions is provided to determine the prevailing opportunities in these geographies.

Hyperphosphatemia Drugs Market Key Segments:

By Product

Calcium-based Phosphate Binders
Aluminum-based Phosphate Binders
Magnesium-based Phosphate Binders
Iron-based Phosphate Binders

By Dosage Form

Tablets
Syrups
Capsules

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- France
- Germany
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Australia
- Japan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 HYPERPHOSPHATEMIA DRUGS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CALCIUM-BASED PHOSPHATE BINDERS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. ALUMINUM-BASED PHOSPHATE BINDERS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. MAGNESIUM-BASED PHOSPHATE BINDERS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. IRON-BASED PHOSPHATE BINDERS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

Chapter: 5 HYPERPHOSPHATEMIA DRUGS MARKET, BY DOSAGE FORMS

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. TABLETS

5.2.1. Market size and forecast

5.3. SYRUPS

5.3.1. Market size and forecast

5.4. CAPSULES

5.4.1. Market size and forecast

Chapter: 6 HYPERPHOSPHATEMIA DRUGS MARKET, BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Hyperphosphatemia Drugs Market by Product
6.2.5. North America Hyperphosphatemia Drugs Market by Dosage Forms

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Spain market size and forecast
6.3.3.5. Rest of Europe market size and forecast

6.3.4. Europe Hyperphosphatemia Drugs Market by Product
6.3.5. Europe Hyperphosphatemia Drugs Market by Dosage Forms

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Hyperphosphatemia Drugs Market by Product
6.4.5. Asia-Pacific Hyperphosphatemia Drugs Market by Dosage Forms

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA Hyperphosphatemia Drugs Market by Product
6.5.5. LAMEA Hyperphosphatemia Drugs Market by Dosage Forms

Chapter: 7 COMPANY PROFILES

7.1. AMAG PHARMACEUTICALS

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. JOHNSON AND JOHNSON

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. KERYX BIOPHARMACEUTICALS

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. DSM BIOTECH PHARMACAL

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. SUN PHARM INC.

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. ZERIA PHARMACEUTICAL

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. BRUNO PHARMACEUTICAL SPA

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. FERMENTA BIOTECH LTD

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. PFIZER INC.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. Roche Diagnostics Corporation

7.9.4. Operating business segments
7.9.5. Business performance
7.9.6. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.